Legal & General Group
ATOS icon

Legal & General Group’s Atossa Therapeutics ATOS Stock Holding History

Legal & General Group’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-789
Closed -$7.96K – 3428
2025
Q1 		$7.96K Hold
789
– – ﹤0.01% 3217
2024
Q4 		$11.2K Hold
789
– – ﹤0.01% 3232
2024
Q3 		$18K Hold
789
– – ﹤0.01% 3089
2024
Q2 		$14.1K Buy
+789
New +$17.5K ﹤0.01% 3168
2022
Q2 		– Sell
-782
Closed -$15K – 3530
2022
Q1 		$15K Hold
782
– – ﹤0.01% 3294
2021
Q4 		$18K Hold
782
– – ﹤0.01% 3303
2021
Q3 		$38K Hold
782
– – ﹤0.01% 3052
2021
Q2 		$74K Buy
+782
New +$41.4K ﹤0.01% 2824

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return